Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer

por Shin, Sol-Bi, Woo, Sang-Uk, Yim, Hyungshin
Publicado 2019

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance

por Shin, Sol-Bi, Kim, Chang-Hyeon, Jang, Hay-Ran, Yim, Hyungshin
Publicado 2020

Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer

por Shin, Sol-Bi, Jang, Hay-Ran, Xu, Rong, Won, Jae-Yeon, Yim, Hyungshin
Publicado 2019

Correction: Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer

por Shin, Sol-Bi, Jang, Hay-Ran, Xu, Rong, Won, Jae-Yeon, Yim, Hyungshin
Publicado 2019

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters

por Shin, Sol-Bi, Kim, Dae-Hoon, Kim, Da-Eun, Aldonza, Mark Borris D., Kim, Yoosik, Yim, Hyungshin
Publicado 2021

PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC

por Kim, Da-Eun, Shin, Sol-Bi, Kim, Chang-Hyeon, Kim, Yeo-Bin, Oh, Hyun-Ji, Yim, Hyungshin
Publicado 2023

Chemiluminescence resonance energy transfer–based nanoparticles for quantum yield–enhanced cancer phototheranostics

por Jeon, Jueun, You, Dong Gil, Um, Wooram, Lee, Jeongjin, Kim, Chan Ho, Shin, Sol, Kwon, Seunglee, Park, Jae Hyung
Publicado 2020

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

por Jang, Hay-Ran, Shin, Sol-Bi, Kim, Chang-Hyeon, Won, Jae-Yeon, Xu, Rong, Kim, Da-Eun, Yim, Hyungshin
Publicado 2021

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

por Jang, Hay-Ran, Shin, Sol-Bi, Kim, Chang-Hyeon, Won, Jae-Yeon, Xu, Rong, Kim, Da-Eun, Yim, Hyungshin
Publicado 2021

Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1

por Shin, Jung Min, Lee, Chan‐Hyeong, Son, Soyoung, Kim, Chan Ho, Lee, Jae Ah, Ko, Hyewon, Shin, Sol, Song, Seok Ho, Park, Seong‐Sik, Bae, Ju‐Hyun, Park, Ju‐Mi, Choe, Eun‐Ji, Baek, Moon‐Chang, Park, Jae Hyung
Publicado 2021

Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseases

por Lim, Gyeong Taek, You, Dong Gil, Han, Hwa Seung, Lee, Hansang, Shin, Sol, Oh, Byeong Hoon, Kumar, E. K. Pramod, Um, Wooram, Kim, Chan Ho, Han, Seungsu, Lee, Sangho, Lim, Seungho, Yoon, Hong Yeol, Kim, Kwangmeyung, Kwon, Ick Chan, Jo, Dong‐Gyu, Cho, Yong Woo, Park, Jae Hyung
Publicado 2021